Elevated serum levels of soluble adhesion molecules predict death in predialysis patients: Association with malnutrition, inflammation, and cardiovascular disease

Nephrology Dialysis Transplantation

Volumn 15, Issue 10, 2000, Pages 1624-1630

  Stenvinkel, Peter ^a   Lindholm, Bengt ^a   Heimbürger, Mikael ^a   Heimbürger, Olof ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular disease; Inflammation; Lp(a); Malnutrition; Mortality; Soluble adhesion molecules

Indexed keywords

ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CELL ADHESION MOLECULE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FUROSEMIDE; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; LIPID; LIPOPROTEIN; PHOSPHATE BINDING AGENT; POTASSIUM; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VITAMIN B GROUP; VITAMIN D;

ADULT; AGE; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CELL SURFACE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DEATH; DIALYSIS; ENDOTHELIUM CELL; FEMALE; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SURVIVAL; VASCULAR ENDOTHELIUM;

EID: 0033815254     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.10.1624     Document Type: Article

References (48)

1. Clinical epidemiology of cardiovascular disease in chronic renal failure
2. Influence of co-morbidity on mortality and morbidity of hemodialysis patients
3. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
4. Factors influencing malnutrition in hemodialysis patients. A cross-sectional study
5. Biological basis of hypoalbuminemia in ESRD
6. Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients
7. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
8. Serum C-reactive (CRP) and risk of death in chronic dialysis patients
9. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study
10. Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure
11. Plasma levels of IL-1β, TNF-α and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients
12. Immunologic function and survival in hemodialysis patients
13. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
14. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients
15. Cytokine production and nutritional status in hemodialysis patients
16. Malnutrition, cardiac disease and mortality-An integrated point of view
17. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome)
18. Endothelial expression of a mononuclear leucocyte adhesion molecule during atherogenesis
19. Molecular bases of the acute coronary syndromes
20. Circulating adhesion molecules in disease
21. Plasma concentrations of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men
22. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases
23. Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis
24. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients
25. Apo(a) isoform size, nutritional status and inflammatory markers in chronic renal failure
26. High serum hyaluronan indicates poor survival in renal replacement therapy
27. A comparison of clinical judgement and objective measurements
28. What is subjective global assessment of nutritional status?
29. Circulating adhesion molecules during kidney allograft rejection
30. Cytokines and endothelial cell biology
31. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatant of cytokine activated cultured endothelial cells
32. Clinical significance of the immunometric measurements of hyaluronic acid
33. Circulating hyaluronate in rheumatoid arthritis: Relationship to inflammatory activity and the effect of corticosteroid therapy
34. Cytokeratin expression and hyaluronic acid production in cultures of human synovial microvascular endothelial cells: Influence of cytokines and growth factors
35. Proinflammatory stimuli regulate hyaluronan expression and CD44/HA-dependent primary adhesion
36. Hyperhyaluronanemia in alcoholic hepatitis is associated with increased levels of circulating soluble intercellular adhesion molecule-1
37. Mechanisms of hyaluronan-induced upregulation of ICAM-1 and VCAM-1 expression by murine kidney epithelial cells: Hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of and activating protein-1
38. Cell adhesion molecules in cardiovascular disease: A clinical perspective
39. Circulating endothelial cell/leucocyte adhesion molecules in atherosclerosis
40. Soluble vascular adhesion molecule-1 as a biohumoral correlate of atherosclerosis
41. Circulating vascular cell adhesion molecule-1 correlates with the extent of human arteriosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin
42. Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction
43. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
44. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age
45. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory dialysis
46. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients
47. Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease
48. Expression of adhesion molecules by Lp(a): A potential novel mechanism for its atherogenicity